The National Health Surveillance Agency (Anvisa) issued a warning about the misuse of pens aimed at treating obesity and diabetes. The document was released this Monday (9). “Although the risk is already included in leaflets approved in Brazil, notifications have increased on the international and national scene, which requires reinforcement of safety guidelines” said the alert.
*Updating
